Chandra Bhagat Pharma Ltd
CBPLChandra Bhagat Pharma Ltd
CBPL
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.87 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Chandra Bhagat Pharma Ltd is an India-based medicine company. The Company is engaged in the business of marketing pharmaceutical formulation and products in domestic and international markets through its distribution network and sales force under its own brand. It provides a range of products portfolio of a pharmaceutical formulation including injections (ampoules, vials, prefilled syringe, lyophilized vials), tablet, capsules and oral syrup. The Company’s products include for the domestic market mufost, mufost, herzovir, herzovir, clauvmentin, falsun, azap, azocin, chinofen, polodyl, casfungen, cbtaz, nuperazone, nuperazone forte, nuperazone plus, nuperazone 3g, cefzidime tz, cefzidime, cezoneplus, cezone tz, myocholine, klarinton, samcy, dobier s, maxiparine, antacer, cbfos, thionine, thromboparin, meplife combipack, merospect and norepirin.
Peers
Compare with peersHemant Surgical Industries Ltd
Achyut Healthcare Ltd
Royal Sense Ltd
Dipna Pharmachem Ltd
Checkpoint Trends Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 80.22 | 90.28 | 97.73 | 106.72 | 94.42 | 71.18 | 95.70 | 119.96 | 232.70 | — | ||||||||||
Raw Materials | 63.07 | 79.16 | 88.28 | 103.64 | 86.26 | 53.78 | 81.44 | 104.57 | 209.06 | — | ||||||||||
| Power & Fuel Cost | 0.00 | 0.09 | 0.09 | 0.09 | 0.08 | 0.05 | 0.07 | 0.07 | 0.09 | |||||||||||
| Employee Cost | 7.26 | 5.64 | 5.02 | 4.53 | 2.25 | 1.85 | 1.52 | 1.32 | 2.18 | |||||||||||
| Selling & Administrative Expenses | 0.00 | 4.62 | 4.65 | 4.22 | 2.42 | 4.85 | 5.45 | 7.30 | 17.75 | |||||||||||
| Operating & Other expenses | 6.08 | -4.10 | -5.57 | -10.80 | -0.15 | 6.48 | 2.76 | 3.08 | -0.66 | |||||||||||
EBITDA | 3.81 | 4.87 | 5.26 | 5.04 | 3.56 | 4.17 | 4.46 | 3.62 | 4.28 | — | ||||||||||
| Depreciation/Amortization | 0.24 | 0.14 | 0.06 | 0.05 | 0.03 | 0.12 | 0.12 | 0.27 | 0.64 | — | ||||||||||
| PBIT | 3.57 | 4.73 | 5.20 | 4.99 | 3.53 | 4.05 | 4.34 | 3.35 | 3.64 | — | ||||||||||
| Interest & Other Items | 2.83 | 3.81 | 3.67 | 4.09 | 3.11 | 3.76 | 3.24 | 2.20 | 1.39 | — | ||||||||||
| PBT | 0.74 | 0.92 | 1.53 | 0.90 | 0.42 | 0.29 | 1.10 | 1.15 | 2.25 | — | ||||||||||
| Taxes & Other Items | 0.37 | 0.25 | 0.50 | 0.20 | 0.11 | 0.09 | 0.30 | 0.25 | 0.74 | — | ||||||||||
| Net Income | 0.37 | 0.67 | 1.03 | 0.70 | 0.31 | 0.20 | 0.80 | 0.90 | 1.51 | — | ||||||||||
| EPS | 8.85 | 16.03 | 24.64 | 12.86 | 0.75 | 0.27 | 1.06 | 1.19 | 2.00 | — | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareHealth Care Distributors
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Chandra Bhagat Pharma Ltd | 35.97 | 1.87 | — |
| Hemant Surgical Industries Ltd | 15.11 | 2.70 | — |
| Achyut Healthcare Ltd | 193.55 | 3.65 | — |
| Royal Sense Ltd | 65.37 | 5.70 | — |
Price Comparison
Compare CBPL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2023
Sep 2023
Mar 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
CBPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeChandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 16.87%, vs industry avg of 16.25%
Decreasing Market Share
Over the last 5 years, market share decreased from 42.62% to 42.36%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 16.62%, vs industry avg of 29.96%